BostonGene Announces $150 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status
Financing Will Expedite R&D, Clinical Expansion, and International Availability of BostonGene Tumor PortraitTM Tests WALTHAM, Mass.–(BUSINESS WIRE)– BostonGene today announced the completion of the $150...